“HPV vaccine could be given to boys as well as girls in UK,” The Guardian reports.
It goes on to say that, “Government advisers are to consider whether the HPV vaccine, routinely offered to girls at the ages of 12 and 13 since 2008 to help protect them against cervical cancer, should also be offered to boys and some men”.
The news appears to be based on draft minutes from the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI advises the government on how vaccinations may reduce health problems – and considers the evidence on factors such as the prevalence of diseases, and the safety and effectiveness of vaccines.
The latest draft minutes of the JCVI say that as part of its work on the HPV vaccine it agreed that “further work was required to consider a number of key issues”, including vaccinating:

men who have sex with men, if they attend sexual health services
adolescent males

Boys are routinely vaccinated against HPV in many other developed nations such as Australia and the US. It’s clear that officials in the UK would want to understand whether such a programme would be safe, effective and provide value for taxpayers’ money.
Who currently gets the HPV vaccine?
A type of HPV vaccine called Gardasil is routinely offered to secondary school girls aged 12 and 13 as part of the NHS childhood vaccination programme. Gardasil protects against the two types of HPV responsib…

Source: NHS News FeedCategory: Consumer Health News Tags: Pregnancy/child Medication QA articles Cancer Source Type: news

Related Links:

Ensuring that adolescent women are able to choose whether and when to have children is crucial to their sexual and reproductive health, yetnew data published today by the Guttmacher Institute show that contraceptive services in developing regions fall short of meeting adolescents ’ needs.

Source: The Guttmacher InstituteCategory: International Medicine & Public Health Authors: Source Type: news

The objective of this attempt at clarification is to discuss the contributions of this discipline to everyday surgical activity, to provide surgeons with some tools facilitating initial evaluation of their patients, and to remind the reader of situations in which oncological assistance is of paramount importance.

ConclusionAppendiceal masses should be considered in the differential diagnosis of a presumed pelvic mass. For low-grade appendiceal mucinous neoplasms that are diagnosed intra-operatively, laparoscopic resection without spillage or rupture is a feasible and appropriate approach for treatment (1,2,3).

Algorithm may help better predict how likely it is a woman will have cancer in her future.

Source: Diagnostic ImagingCategory: Radiology Authors: Tags: Breast Imaging Dense Breasts Source Type: news

CONCLUSION: In cases of male fertility disorders a microbiological clarification is recommended. Further studies on the effect of STI on male fertility in larger collectives are necessary, particularly for Caucasian populations. The utilization of existing preventive measures, such as screening for Chlamydia in young women and HPV vaccination also for young males, should be intensively promoted.
PMID: 30406812 [PubMed – as supplied by publisher]

Source: BMJ CommentsCategory: General Medicine Source Type: forums

Conclusion: MRI-linac based single dose APBI to the intact tumor is a promising and a dosimetrically feasible strategy in patients with low-risk breast cancer. Preliminary OAR dosimetry favored the prone radiotherapy position.
PMID: 30406210 [PubMed]

Source: Clinical Lung CancerCategory: Cancer & Oncology Authors: Tags: Clin Transl Radiat Oncol Source Type: research

One of the biotech industry’s largest unicorns, Cambridge-based Moderna Therapeutics, is planning to go public with an IPO of as much as $500 million, according to documents filed Friday.

Moderna is developing messenger RNA molecules, including cancer vaccines, that executives estimates could impact dozens of diseases. The company currently has 10 drug products in clinical trials and another 11 drugs in preclinical development.

The company filed documents with the SEC on Friday t o seek up to…

This study aimed to evaluate the immunostaining of HIF-1α, NOTCH1, ADAM12, and HBEGF in 19 cases of mucoepidermoid carcinoma (MEC) and 10 samples of salivary glands (control group).Study DesignThe immunoperoxidase technique was employed to detect the proteins of interest. The Student t test was used to compare immunoexpression between MEC samples and the control group.ResultsProtein immunostaining was statistically significantly higher in MEC samples than in the control group (P

Curriculum transformation, An expanded role, Gaining recognition, Graduate match rate; School of Pharmacy scientists receive UCSF Medal: Founding fathers of drug discovery honored; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Advancing the fight against cancer, Combining drug therapies, Mapping cells; In memoriam: Robert D. Gibson
A lifetime of pharmacy and advocacy


Source link


Please enter your comment!
Please enter your name here